Ryosuke Shirasaki

738 total citations
33 papers, 156 citations indexed

About

Ryosuke Shirasaki is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Ryosuke Shirasaki has authored 33 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 15 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Ryosuke Shirasaki's work include Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (6 papers). Ryosuke Shirasaki is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (6 papers). Ryosuke Shirasaki collaborates with scholars based in Japan, United States and Netherlands. Ryosuke Shirasaki's co-authors include Haruko Tashiro, Naoki Shirafuji, Tadashi Yamamoto, Kazuo Kawasugi, Hirotoshi Kikuchi, Kurumi Asako, Yasuo Ono, Constantine S. Mitsiades, Jonathan J. Keats and Shannon M. Matulis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Ryosuke Shirasaki

28 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Shirasaki Japan 6 102 63 49 33 26 33 156
Luděk Pour Czechia 8 61 0.6× 79 1.3× 69 1.4× 51 1.5× 25 1.0× 88 206
Nicola Sgherza Italy 8 98 1.0× 54 0.9× 37 0.8× 26 0.8× 73 2.8× 33 196
Hélène Guermouche France 8 59 0.6× 44 0.7× 50 1.0× 39 1.2× 44 1.7× 12 170
Santosh Narat United Kingdom 4 147 1.4× 64 1.0× 59 1.2× 46 1.4× 19 0.7× 5 208
Ayed O. Ayed United States 6 83 0.8× 19 0.3× 41 0.8× 39 1.2× 50 1.9× 11 153
Valeria Cancelli Italy 9 138 1.4× 82 1.3× 62 1.3× 15 0.5× 26 1.0× 24 200
Mac Macheta United Kingdom 6 145 1.4× 95 1.5× 29 0.6× 44 1.3× 51 2.0× 13 282
Asu Fergün Yılmaz Türkiye 5 103 1.0× 22 0.3× 32 0.7× 19 0.6× 40 1.5× 20 147
Fatima Zahra Jelloul United States 8 92 0.9× 61 1.0× 63 1.3× 23 0.7× 34 1.3× 32 172
James H. Jerkins United States 9 164 1.6× 33 0.5× 72 1.5× 77 2.3× 32 1.2× 27 226

Countries citing papers authored by Ryosuke Shirasaki

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Shirasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Shirasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Shirasaki more than expected).

Fields of papers citing papers by Ryosuke Shirasaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Shirasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Shirasaki. The network helps show where Ryosuke Shirasaki may publish in the future.

Co-authorship network of co-authors of Ryosuke Shirasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Shirasaki. A scholar is included among the top collaborators of Ryosuke Shirasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Shirasaki. Ryosuke Shirasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Kensuke, et al.. (2025). Guillain-Barré syndrome with T-cell receptor gene clonal rearrangement following COVID-19 vaccination: a case report. Clinical and Experimental Vaccine Research. 14(3). 294–294.
2.
Garcia-Rivera, Enrique, Dylan C. Mitchell, Joel M. Chick, et al.. (2025). Highly specific intracellular ubiquitination of a small molecule. Nature Chemical Biology. 1 indexed citations
3.
Tashiro, Haruko, Ryosuke Shirasaki, Tadashi Yamamoto, et al.. (2022). The FLT3 internal tandem duplication mutation at disease diagnosis is a negative prognostic factor in myelodysplastic syndrome patients. Leukemia Research. 113. 106790–106790. 2 indexed citations
4.
Gupta, Vikas A., Benjamin G. Barwick, Shannon M. Matulis, et al.. (2021). Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression. Blood. 137(26). 3604–3615. 54 indexed citations
5.
Dashevsky, Olga, Ricardo De Matos Simoes, Benjamin G. Barwick, et al.. (2021). Functional Genomic and Immune Response Characterization of PTEN Loss: Therapeutic Implications for Myeloma. Blood. 138(Supplement 1). 1612–1612.
6.
Tashiro, Haruko, et al.. (2020). Functional expression cloning of molecules inducing CD34 expression in bone marrow-derived stromal myofibroblasts. Biochemical and Biophysical Research Communications. 533(4). 1283–1289. 1 indexed citations
7.
Shirasaki, Ryosuke, Ricardo De Matos Simoes, Sondra L. Downey-Kopyscinski, et al.. (2020). Mechanisms Regulating Myeloma Cell Responsiveness to Antisense Oligonucleotides Targeting IRF4. Blood. 136(Supplement 1). 32–32. 1 indexed citations
8.
Dashevsky, Olga, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2020). Use of Olfactory Receptor Genes As Controls for Genome-Scale CRISPR Functional Genomic Studies to Define Treatment Resistance Mechanisms. Blood. 136(Supplement 1). 36–36.
9.
Gandolfi, Sara, Michal Sheffer, Olga Dashevsky, et al.. (2019). Molecular markers of MM cell sensitivity and resistance to Natural Killer cells: implications for anti-MM immunotherapy. Clinical Lymphoma Myeloma & Leukemia. 19(10). e168–e169. 1 indexed citations
10.
Tashiro, Haruko, Ryosuke Shirasaki, Masato Watanabe, et al.. (2018). Direct Factor X sequestration by systemic amyloid light‐chain amyloidosis. Clinical Case Reports. 6(3). 513–515. 3 indexed citations
11.
Tang, Huihui, Ricardo De Matos Simoes, Ryosuke Shirasaki, et al.. (2018). CRISPR Activation Screen for HDAC Inhibitor Resistance. Blood. 132(Supplement 1). 3958–3958. 1 indexed citations
12.
Gandolfi, Sara, Olga Dashevsky, Ricardo De Matos Simoes, et al.. (2017). Long-Term Interactions with Bone Marrow Stromal Cells Alter the Molecular Dependencies of Myeloma Cells: Insights from Genomewide CRISPR-Based Functional Genomic Screens. Blood. 130. 3028–3028. 1 indexed citations
13.
Shirasaki, Ryosuke, Haruko Tashiro, Tadashi Yamamoto, et al.. (2011). Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19). International Journal of Hematology. 94(2). 203–208. 3 indexed citations
14.
Kikuchi, Hirotoshi, et al.. (2011). Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus. Modern Rheumatology. 22(2). 308–311. 19 indexed citations
15.
Tashiro, Haruko, Ryosuke Shirasaki, Tadashi Yamamoto, et al.. (2011). Interleukin-1β Promotes the Expression of CD34 and Granulocyte Colony-Stimulating Factor-Receptor in Adult Dermal Fibroblasts. Blood. 118(21). 4815–4815. 1 indexed citations
16.
17.
Kawasugi, Kazuo, Tadashi Yamamoto, Ryosuke Shirasaki, Haruko Tashiro, & Naoki Shirafuji. (2010). Increased Levels of Histone In Human Plasma In Septic Patients with DIC.. Blood. 116(21). 1422–1422. 1 indexed citations
18.
Tashiro, Haruko, Ryosuke Shirasaki, Toshiyuki Miura, et al.. (2009). Successful unrelated bone marrow transplantation for a human immunodeficiency virus type-1-seropositive acute myelogenous leukemia patient following HAART. International Journal of Hematology. 91(1). 140–145. 3 indexed citations
19.
Tashiro, Haruko, et al.. (2009). Acute myelogenous leukemia cells with the MLL–ELL translocation convert morphologically and functionally into adherent myofibroblasts. Biochemical and Biophysical Research Communications. 391(1). 592–597. 6 indexed citations
20.
Tashiro, Haruko, et al.. (2006). Molecular Analysis of Chronic Eosinophilic Leukemia with t(4;10) Showing Good Response to Imatinib Mesylate. International Journal of Hematology. 83(5). 433–438. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Nicola Sgherza Breakdown of academic impact, for papers by Hélène Guermouche Breakdown of academic impact, for papers by Santosh Narat Breakdown of academic impact, for papers by Ayed O. Ayed Breakdown of academic impact, for papers by Valeria Cancelli Breakdown of academic impact, for papers by Mac Macheta Breakdown of academic impact, for papers by Asu Fergün Yılmaz Breakdown of academic impact, for papers by Fatima Zahra Jelloul Breakdown of academic impact, for papers by James H. Jerkins
Rankless by CCL
2026